Ceftazidime Synthesis: The Essential Role of (Z)-2-Amino-alpha-[1-(tert-butoxycarbonyl)]-1-methylethoxyimino-4-thiazolacetic Acid
The production of advanced pharmaceutical compounds often hinges on the availability of precisely engineered chemical intermediates. For the synthesis of Ceftazidime, a critically important antibiotic, (Z)-2-Amino-alpha-[1-(tert-butoxycarbonyl)]-1-methylethoxyimino-4-thiazolacetic acid (CAS: 86299-47-0) plays an essential role. This article explores the significance of this intermediate and highlights the benefits of sourcing it from a reputable manufacturer such as NINGBO INNO PHARMCHEM CO., LTD.
Ceftazidime is a third-generation cephalosporin with a broad spectrum of activity, widely prescribed for treating serious bacterial infections. The synthesis of such a complex molecule requires a high level of precision, starting with high-quality raw materials and intermediates. (Z)-2-Amino-alpha-[1-(tert-butoxycarbonyl)]-1-methylethoxyimino-4-thiazolacetic acid provides the necessary structural framework and functional groups, ensuring the efficiency and success of the subsequent synthetic steps.
NINGBO INNO PHARMCHEM CO., LTD. is a specialized manufacturer and supplier of pharmaceutical intermediates, committed to delivering products that meet the highest standards of purity and consistency. Our supply of (Z)-2-Amino-alpha-[1-(tert-butoxycarbonyl)]-1-methylethoxyimino-4-thiazolacetic acid is backed by rigorous quality control and a deep understanding of chemical synthesis. We aim to provide our clients with a cost-effective and reliable source for this essential component, thereby supporting the uninterrupted production of vital antibiotics. When you need to buy this intermediate, our team is ready to assist you.
The pharmaceutical industry’s demands for advanced chemical building blocks are ever-increasing. NINGBO INNO PHARMCHEM CO., LTD. is dedicated to meeting these needs by offering a wide range of high-quality intermediates. We invite pharmaceutical companies and research institutions to partner with us for their sourcing requirements, confident in our ability to deliver excellence in both product and service.
Ceftazidime is a third-generation cephalosporin with a broad spectrum of activity, widely prescribed for treating serious bacterial infections. The synthesis of such a complex molecule requires a high level of precision, starting with high-quality raw materials and intermediates. (Z)-2-Amino-alpha-[1-(tert-butoxycarbonyl)]-1-methylethoxyimino-4-thiazolacetic acid provides the necessary structural framework and functional groups, ensuring the efficiency and success of the subsequent synthetic steps.
NINGBO INNO PHARMCHEM CO., LTD. is a specialized manufacturer and supplier of pharmaceutical intermediates, committed to delivering products that meet the highest standards of purity and consistency. Our supply of (Z)-2-Amino-alpha-[1-(tert-butoxycarbonyl)]-1-methylethoxyimino-4-thiazolacetic acid is backed by rigorous quality control and a deep understanding of chemical synthesis. We aim to provide our clients with a cost-effective and reliable source for this essential component, thereby supporting the uninterrupted production of vital antibiotics. When you need to buy this intermediate, our team is ready to assist you.
The pharmaceutical industry’s demands for advanced chemical building blocks are ever-increasing. NINGBO INNO PHARMCHEM CO., LTD. is dedicated to meeting these needs by offering a wide range of high-quality intermediates. We invite pharmaceutical companies and research institutions to partner with us for their sourcing requirements, confident in our ability to deliver excellence in both product and service.
Perspectives & Insights
Core Pioneer 24
“is dedicated to meeting these needs by offering a wide range of high-quality intermediates.”
Silicon Explorer X
“We invite pharmaceutical companies and research institutions to partner with us for their sourcing requirements, confident in our ability to deliver excellence in both product and service.”
Quantum Catalyst AI
“The production of advanced pharmaceutical compounds often hinges on the availability of precisely engineered chemical intermediates.”